222.62

0.61% 1.35

After Hours: 222.77 0.15 +0.07%

Cardinal Health Inc (CAH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Cardinal Health Inc stock is traded at $222.62, with a volume of 3.02M. It is up +0.61% in the last 24 hours and down -4.20% over the past month. Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Previous Close:

$221.27

Open:

$222.08

24h Volume:

3.02M

Relative Volume:

1.53

Market Cap:

$51.55B

Revenue:

$250.74B

Net Income/Loss:

$1.55B

P/E Ratio:

34.04

EPS:

6.5398

Net Cash Flow:

$4.39B

1W Performance:

-1.64%

1M Performance:

-4.20%

6M Performance:

+7.43%

1Y Performance:

+44.02%

1-Day Range:

$221.95

$225.37

1-Week Range:

$220.94

$228.44

52-Week Range:

$145.87

$258.30

Cardinal Health Inc Stock (CAH) Company Profile

Name

Cardinal Health Inc

Sector

Healthcare (1068)

Industry

Medical Distribution (11)

Phone

(614) 757-3033

Address

7000 CARDINAL PLACE, DUBLIN, OH

Employee

57,700

Twitter

@cardinalhealth

Next Earnings Date

2026-10-29

Latest SEC Filings

CAH's Discussions on Twitter

Compare CAH vs MCK, COR, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CAH Cardinal Health Inc	222.62	51.24B	250.74B	1.55B	4.39B	6.5398
MCK Mckesson Corp	869.36	102.66B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	309.87	59.59B	328.68B	2.55B	1.56B	13.03
HSIC Henry Schein Inc	85.53	9.48B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	0.76	659.58M	14.85M	-136.07M	7.25M	-0.4726

Cardinal Health Inc Stock (CAH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-09-26	Upgrade	Citigroup	Neutral → Buy
Dec-09-25	Initiated	Barclays	Overweight
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Feb-05-25	Upgrade	Jefferies	Hold → Buy
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-25	Upgrade	BofA Securities	Neutral → Buy
Dec-13-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-04-24	Resumed	Mizuho	Outperform
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Upgrade	Argus	Hold → Buy
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Underweight
Jul-10-23	Downgrade	Evercore ISI	Outperform → In-line
Mar-31-23	Initiated	Citigroup	Neutral
Feb-03-23	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-04-22	Upgrade	BofA Securities	Underperform → Neutral
Aug-22-22	Resumed	Morgan Stanley	Overweight
May-26-22	Downgrade	Barclays	Overweight → Equal Weight
May-18-22	Upgrade	Evercore ISI	In-line → Outperform
Apr-12-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-01-22	Resumed	Credit Suisse	Neutral
Aug-06-21	Downgrade	Deutsche Bank	Buy → Hold
Aug-05-21	Downgrade	BofA Securities	Buy → Underperform
May-10-21	Downgrade	Robert W. Baird	Outperform → Neutral
Jan-08-21	Upgrade	Wolfe Research	Underperform → Peer Perform
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Sep-25-20	Upgrade	Deutsche Bank	Hold → Buy
Jul-20-20	Upgrade	Guggenheim	Neutral → Buy
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-20-20	Upgrade	BofA/Merrill	Underperform → Buy
Feb-12-20	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Dec-16-19	Downgrade	Guggenheim	Buy → Neutral
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-27-19	Downgrade	Argus	Buy → Hold
Aug-20-19	Upgrade	Guggenheim	Neutral → Buy
Apr-18-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Nov-16-18	Downgrade	Leerink Partners	Outperform → Mkt Perform
Apr-24-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
Apr-02-18	Upgrade	Argus	Hold → Buy
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Underperform
Jan-05-18	Initiated	Evercore ISI	In-line

View All

Cardinal Health Inc Stock (CAH) Latest News

01:12 AM

Cardinal Health (CAH) Stock Looks About Right At Today’s Price - finance.yahoo.com

01:12 AM

12:20 PM

Cardinal Health stock gains 1.47 percent on fiscal growth - ad-hoc-news.de

12:20 PM

11:45 AM

Cardinal Health vs. McKesson: Which Healthcare Stock Is Better? - uk.finance.yahoo.com

11:45 AM

01:42 AM

Cardinal Health stock slips 0.3 percent ahead of the open - ad-hoc-news.de

01:42 AM

Sep 23, 2026

Cardinal Health stock falls 1.64 percent as estimates point to growth - ad-hoc-news.de

Sep 23, 2026

Cardinal Health stock slips 1.64 percent ahead of the open - ad-hoc-news.de

Sep 23, 2026

Sep 22, 2026

Cardinal Health (CAH) Stock Moves -1.64%: What You Should Know - finance.yahoo.com

Sep 22, 2026

Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 22, 2026

Cardinal Health Legal Chief's Pay Jumped To $5.5M Last Year - Law360

Sep 22, 2026

Form DEF 14A Cardinal Health For: 22 September By Investing.com - Investing.com Australia

Sep 22, 2026

CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now? - TradingView

Sep 22, 2026

Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True? - Zacks Investment Research

Sep 22, 2026